Sonnet BioTherapeutics Holdings Other Assets

The latest other assets for SONN is $0 as of September 2025. In the prior-year period, the figure was $0. Investors often review this figure alongside Sonnet BioTherapeutics Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, SONN's other assets moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sonnet BioTherapeutics Holdings's operating scale or balance-sheet position.

A other assets figure of $0 for SONN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SONN's other assets ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sonnet BioTherapeutics Holdings's other assets against similar Consumer Staples names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Staples companies and their key multiples and fundamentals.